Literature DB >> 12024215

Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite.

Junitsu Ito1, Anil Ghosh, Luciano A Moreira, Ernst A Wimmer, Marcelo Jacobs-Lorena.   

Abstract

Malaria is estimated to cause 0.7 to 2.7 million deaths per year, but the actual figures could be substantially higher owing to under-reporting and difficulties in diagnosis. If no new control measures are developed, the malaria death toll is projected to double in the next 20 years. Efforts to control the disease are hampered by drug resistance in the Plasmodium parasites, insecticide resistance in mosquitoes, and the lack of an effective vaccine. Because mosquitoes are obligatory vectors for malaria transmission, the spread of malaria could be curtailed by rendering them incapable of transmitting parasites. Many of the tools required for the genetic manipulation of mosquito competence for malaria transmission have been developed. Foreign genes can now be introduced into the germ line of both culicine and anopheline mosquitoes, and these transgenes can be expressed in a tissue-specific manner. Here we report on the use of such tools to generate transgenic mosquitoes that express antiparasitic genes in their midgut epithelium, thus rendering them inefficient vectors for the disease. These findings have significant implications for the development of new strategies for malaria control.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12024215     DOI: 10.1038/417452a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  155 in total

1.  Plagues and peoples revisited. Basic and strategic research for ingectious disease control at the intergace in the life, health and social sciences.

Authors:  Johannes Sommerfeld
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Wolbachia and cytoplasmic incompatibility in the California Culex pipiens mosquito species complex: parameter estimates and infection dynamics in natural populations.

Authors:  Jason L Rasgon; Thomas W Scott
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

3.  Site-specific selfish genes as tools for the control and genetic engineering of natural populations.

Authors:  Austin Burt
Journal:  Proc Biol Sci       Date:  2003-05-07       Impact factor: 5.349

4.  Use of Wolbachia to drive nuclear transgenes through insect populations.

Authors:  Steven P Sinkins; H Charles J Godfray
Journal:  Proc Biol Sci       Date:  2004-07-07       Impact factor: 5.349

Review 5.  Safe and fit genetically modified insects for pest control: from lab to field applications.

Authors:  F Scolari; P Siciliano; P Gabrieli; L M Gomulski; A Bonomi; G Gasperi; A R Malacrida
Journal:  Genetica       Date:  2010-08-20       Impact factor: 1.082

6.  Semele: a killer-male, rescue-female system for suppression and replacement of insect disease vector populations.

Authors:  John M Marshall; Geoffrey W Pittman; Anna B Buchman; Bruce A Hay
Journal:  Genetics       Date:  2010-11-15       Impact factor: 4.562

7.  Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen.

Authors:  Rhoel R Dinglasan; Dario E Kalume; Stefan M Kanzok; Anil K Ghosh; Olga Muratova; Akhilesh Pandey; Marcelo Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-02       Impact factor: 11.205

8.  Evolutionary history of a mosquito endosymbiont revealed through mitochondrial hitchhiking.

Authors:  Jason L Rasgon; Anthony J Cornel; Thomas W Scott
Journal:  Proc Biol Sci       Date:  2006-07-07       Impact factor: 5.349

9.  Fitness of anopheline mosquitoes expressing transgenes that inhibit Plasmodium development.

Authors:  Luciano A Moreira; Jing Wang; Frank H Collins; Marcelo Jacobs-Lorena
Journal:  Genetics       Date:  2004-03       Impact factor: 4.562

Review 10.  Molecular genetic manipulation of vector mosquitoes.

Authors:  Olle Terenius; Osvaldo Marinotti; Douglas Sieglaff; Anthony A James
Journal:  Cell Host Microbe       Date:  2008-11-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.